United Kingdom · Seed startup

Who invested in Green Park Pharma

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Raised 10 months ago

Funding summaryUpdated 26 Oct 2026

$3.0Mraised across 1 round since 2026, from 1 source

Latest round
Seed, $3.0MJan 2026
Investors
1
See who backed them

The rounds

  1. Jan 2026
    Seed$3.0M

    Source recorded

Founders and team

From Green Park Pharma's own website: 1 founder, 8 on the team.

Richard ReavleyFounder, Group CEO
  • Chris GrimesCEO Green Park Pharma UK
  • Dr. Hannah GriffithChief Scientific Officer
  • Bill WildFinance Director
  • David HutchinsonCommercial Director
  • John GreensladeNon-Exec Director
  • Jon BoylanPartnership Director
  • Natasha HeerSupply Chain Director
  • Steve ChurchExecutive Chairman

AdvisersDr Hugh Goodfellow

Everyone who backed them

British Business BankCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Green Park Pharma

Who invested in Green Park Pharma?

Green Park Pharma's investors include British Business Bank.

How much has Green Park Pharma raised?

Green Park Pharma has raised $3.0M across 1 round since 2026.

When did Green Park Pharma last raise?

Green Park Pharma's most recent round was a Seed of $3.0M in Jan 2026.

What was Green Park Pharma's biggest round?

Its most recent round, $3.0M in Jan 2026, is also its largest on record.

Who backed Green Park Pharma first?

Green Park Pharma's first round on record, in Jan 2026, was backed by British Business Bank.

What stage is Green Park Pharma at?

Green Park Pharma's latest named round is a Seed, in Jan 2026.

Where is Green Park Pharma based?

Green Park Pharma is based in the United Kingdom.

Companies like Green Park Pharma

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.